Skip to main content
SpringerLink
Log in

Role of Chemokines in the Regulation of Th1/Th2 and Autoimmune Encephalomyelitis

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Chemokines are low molecular weight chemotactic peptides that bind seven transmembrane-spanning, G protein-coupled receptors and deliver signals leading to T cell costimulation, hematopoeisis, cytokine expression, T cell differentiation, and integrin activation. Experimental autoimmune encephalomyelitis (EAE) is a CD4+ Th1-mediated demyelinating disease of the central nervous system (CNS) that serves as a model for multiple sclerosis (MS). A hallmark in the pathogenesis of this CNS demyelinating disease is the emigration of T cells and monocytes from the blood to the CNS. There are several considerations that suggest a role for chemokines in the influx of inflammatory cells and the resulting disease process including a tight temporal expression pattern with relationship to disease activity and prevention of disease development by in vivo neutralization. We review the evidence that temporal and spatial expressions of chemokines are crucial factors, complementing adhesion molecule upregulation, that regulate EAE and potentially MS disease activity as well as the functions of chemokines in Th1 and Th2 biology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Arnason BG: Relevance of experimental allergic encephalomyelitis to multiple sclerosis. Neurol Clin 1:765–782, 1983

    Google Scholar 

  2. McRae BL, Kennedy MK, Tan LJ, Dal Canto MC, Miller SD: Induction of active and adoptive chronic-relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J Neuroimmunol 38:229–240, 1992

    Google Scholar 

  3. Tuohy VK, Sobel RA, Lu Z, Laursen RA, Lees MB: Myelin proteolipid protein: minimum sequence requirements for active induction of autoimmune encephalomyelitis in SWR/J and SJL/J mice. J Neuroimmunol 39:67–74, 1992

    Google Scholar 

  4. Whitham RH, Bourdette DN, Hashim GA, Herndon RM, Ilg RC, Vandenbark AA, Offner H: Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J Immunol 146:101–107, 1991

    Google Scholar 

  5. Hickey WF, Gonatas NK, Kimura H, Wilson DB: Identification and quantitation of T lymphocyte subsets found in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis. J Immunol 131:2805–2809, 1983

    Google Scholar 

  6. Cross AH, Cannella B, Brosnan CF, Raine CS: Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab Invest 63:162–170, 1990

    Google Scholar 

  7. Pope JG, Karpus WJ, Vanderlugt C, Miller SD: Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theiler's virus-induced demyelinating disease—Evidence for a CD4+ T cell-mediated pathology. J Immunol 156:4050–4058, 1996

    Google Scholar 

  8. Baggiolini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines—CXC and CC chemokines. Adv Immunol 55:97–179, 1994

    Google Scholar 

  9. Luster AD: Chemokines—Chemotactic cytokines that mediate inflammation. N Engl J Med 338:436–445, 1998

    Google Scholar 

  10. Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Bazan JF, Moore KW, Schall TJ, Zlotnik A: Lymphotactin: A cytokine that represents a new class of chemokine. Science 266:1395–1399, 1994

    Google Scholar 

  11. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ: A new class of membrane-bound chemokine with a CX3C motif. Nature 385:640–644, 1997

    Google Scholar 

  12. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, Chan SY, Roczniak S, Shanafelt AB: The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270:27348–27357, 1995

    Google Scholar 

  13. Davatelis G, Tekamp-Olson P, Wolpe SD, Hermsen K, Luedke C, Gallegos C, Coit D, Merryweather J, Cerami A: Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokine properties. J Exp Med 167:1939–1944, 1988

    Google Scholar 

  14. Schall TJ: Biology of the RANTES/SIS cytokine family. Cytokine 3:165–183, 1991

    Google Scholar 

  15. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ: Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1α and MIP-1β. Science 260:355–358, 1993

    Google Scholar 

  16. Hedrick JA, Saylor V, Figueroa D, Mizoue L, Xu YM, Menon S, Abrams J, Handel T, Zlotnik A: Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. J Immunol 158:1533–1540, 1997

    Google Scholar 

  17. Mosmann TR, Coffman RL: Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145–174, 1989

    Google Scholar 

  18. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 383:787–793, 1996

    Google Scholar 

  19. Bradley LM, Asensio VC, Schioetz LK, Harbertson J, Krahl T, Patstone G, Woolf N, Campbell IL, Sarvetnick N: Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J Immunol 162:2511–2520, 1999

    Google Scholar 

  20. Schrum S, Probst P, Fleischer B, Zipfel PF: Synthesis of the CC-chemokines MIP-1α, MIP-1β, and RANTES is associated with a type 1 immune response. J Immunol 157:3598–3604, 1996

    Google Scholar 

  21. Li L, Xia Y, Nguyen A, Feng L, Lo D: Th2-induced eotaxin expression and eosinophilia coexist with Th1 responses at the effector stage of lung inflammation. J Immunol 161:3128–3135, 1998

    Google Scholar 

  22. Herold KC, Lu J, Rulifson I, Vezys V, Taub D, Grusby MJ, Bluestone JA: Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation. J Immunol. 159:4150–4153, 1997

    Google Scholar 

  23. Lukacs NW, Kunkel SL, Strieter RM, Warmington K, Chensue SW: The role of macrophage inflammatory protein 1α in Shistosoma mansoni egg-induced granulomatous inflammation. J Exp Med 177:1551–1559, 1993

    Google Scholar 

  24. Chensue SW, Warmington KS, Lukacs NW, Lincoln PM, Burdick MD, Strieter RM, Kunkel SL: Monocyte chemotactic protein expression during schistosome egg granuloma formation. Sequence of production, localization, contribution, and regulation. Am J Pathol 146:130–138, 1995

    Google Scholar 

  25. Lukacs NW, Chensue SW, Karpus WJ, Lincoln P, Keefer C, Strieter RM, Kunkel SL: C-C chemokines differentially alter interleukin-4 production from lymphocytes. Am J Pathol 150:1861–1868, 1997

    Google Scholar 

  26. Karpus WJ, Lukacs NW, Kennedy KJ, Smith WS, Hurst SD, Barrett TA: Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 158:4129–4136, 1997

    Google Scholar 

  27. Kim CH, Broxmeyer HE: Chemokines: Signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol 65:6–15, 1999

    Google Scholar 

  28. Ward SG, Bacon K, Westwick J: Chemokines and T lymphocytes: More than an attraction. Immunity 9:1–11, 1998

    Google Scholar 

  29. Zaballos A, Gutierrez J, Varona R, Ardavin C, Marquez G: Cutting edge: Identification of the orphan chemokine receptor GPR–9–6 as CCR9, the receptor for the chemokine TECK. J Immunol 162:5671–5675, 1999

    Google Scholar 

  30. Yoshida R, Imai T, Hieshima K, Kusuda J, Baba M, Kitaura M, Nishimura M, Kakizaki M, Nomiyama H, Yoshie O: Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J Biol Chem 272:13803–13809, 1997

    Google Scholar 

  31. Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR: The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 94:1925–1930, 1997

    Google Scholar 

  32. Loetscher P, Seitz M, Baggiolini M, Moser B: Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 184:569–577, 1996

    Google Scholar 

  33. Baggiolini M: Chemokines and leukocyte traffic. Nature 392:565–568, 1998

    Google Scholar 

  34. Sallusto F, Mackay CR, Lanzavecchia A: Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005–2007, 1997

    Google Scholar 

  35. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187:875–883, 1998

    Google Scholar 

  36. Uguccioni M, Mackay CR, Ochensberger B, Loetscher P, Rhis S, LaRosa GJ, Rao P, Ponath PD, Baggiolini M, Dahinden CA: High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 100:1137–1143, 1997

    Google Scholar 

  37. Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP, Newman W, Gerard, Mackay CR: Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils [see comments]. J Exp Med 183:2437–2448, 1996

    Google Scholar 

  38. Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Wang J, Gray PW, Matsushima K, Yoshie O: Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 11:81–88, 1999

    Google Scholar 

  39. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129–134, 1998

    Google Scholar 

  40. Luster AD, Ravetch JV: Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med 166:1084–1097, 1987

    Google Scholar 

  41. Farber JM: Mig and IP-10: CXC chemokines that target lymphocytes. J Leukocyte Biol 61:246–257, 1997

    Google Scholar 

  42. Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, Lin W, Boyd JG, Moser B, Wood DE, Sahagan BG, Neote K: Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 187:2009–2021, 1998

    Google Scholar 

  43. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C, Dayer JM: CCR5 is characteristic of Th1 lymphocytes. Nature 391:344–345, 1998

    Google Scholar 

  44. Siveke JT, Hamann A: T helper 1 and T helper 2 cells respond differentially to chemokines. J Immunol 160:550–554, 1998

    Google Scholar 

  45. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR: The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101:746–754, 1998

    Google Scholar 

  46. Balashov KE, Rottman JB, Weiner HL, Hancock WW: CCR5+ and CXCR+ T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA 96:6873–6878, 1999

    Google Scholar 

  47. Sorensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM: Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103:807–815, 1999

    Google Scholar 

  48. Bennetts BH, Teutsch SM, Buhler MM, Heard RN, Stewart GJ: The CCR5 deletion mutation fails to protect against multiple sclerosis. Hum Immunol 58:52–59, 1997

    Google Scholar 

  49. Jiang Y, Salafranca MN, Adhikari S, Xia Y, Feng L, Sonntag MK, deFiebre CM, Pennell NA, Streit WJ, Harrison JK: Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis. J Neuroimmunol 86:1–12, 1998

    Google Scholar 

  50. Hulkower K, Brosnan CF, Aquino DA, Cammer W, Kulshrestha S, Guida MP, Rapoport DA, Berman JW: Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J Immunol 150:2525–2533, 1993

    Google Scholar 

  51. Ransohoff RM, Hamilton TA, Tani M, Stoler MH, Shick HE, Major JA, Estes ML, Thomas DM, Tuohy VK: Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7:592–600, 1993

    Google Scholar 

  52. Godiska R, Chantry D, Dietsch GN, Gray PW: Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol 58:167–176, 1995

    Google Scholar 

  53. Glabinski AR, Tani M, Tuohy VK, Tuthill RJ, Ransohoff RM: Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain Behav Immun 9:315–330, 1995

    Google Scholar 

  54. Glabinski AR, Tuohy VK, Ransohoff RM: Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis. Neuroimmunomodulation 5:166–171, 1998

    Google Scholar 

  55. Miyagishi R, Kikuchi S, Takayama C, Inoue Y, Tashiro K: Identification of cell types producing RANTES, MIP-1α, and MIP-1β in rat experimental autoimmune encephalomyelitis by in situ hybridization. J Neuroimmunol 77:17–26, 1997

    Google Scholar 

  56. Glabinski AR, Tani M, Strieter RM, Tuohy VK, Ransohoff RM: Synchronous synthesis of α-and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol 150:617–630, 1997

    Google Scholar 

  57. Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD: An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 155:5003–5010, 1995

    Google Scholar 

  58. Kennedy KJ, Strieter RM, Kunkel SL, Lukacs NW, Karpus WJ: Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1. J Neuroimmunol 92:98–108, 1998

    Google Scholar 

  59. Tuohy VK, Lu Z, Sobel RA, Laursen RA, Lees MB: Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol 142:1523–1527, 1989

    Google Scholar 

  60. Karpus WJ, Kennedy KJ: MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J Leukocyte Biol 62:681–687, 1997

    Google Scholar 

  61. Yu M, Nishiyama A, Trapp BD, Tuohy VK: Interferon-β inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. J Neuroimmunol 64:91–100, 1996

    Google Scholar 

  62. Ransohoff RM, Glabinski A, Tani M: Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev 7:35–46, 1996

    Google Scholar 

  63. Glabinski AR, Krakowski M, Han Y, Owens T, Ransohoff RM: Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis. J Neurovirol 5:95–101, 1999

    Google Scholar 

  64. Karpus WJ, Ransohoff RM: Chemokine regulation of experimental autoimmune encephalomyelitis: Temporal and spatial expression patterns govern disease pathogenesis. J Immunol 161:2667–2671, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Immunobiology Center, Robert H. Lurie Cancer Center, and Institute for Neuroscience, Northwestern University Medical School, Chicago, Ilinois, 60611

    Kevin J. Kennedy & William J. Karpus

Authors
  1. Kevin J. Kennedy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William J. Karpus
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kennedy, K.J., Karpus, W.J. Role of Chemokines in the Regulation of Th1/Th2 and Autoimmune Encephalomyelitis. J Clin Immunol 19, 273–279 (1999). https://doi.org/10.1023/A:1020535423465

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020535423465

Search

Navigation